Synagis®
Our diligent tracking and monitoring of patients receiving Synagis® is unsurpassed.
APS provides cutting-edge self-injectable therapies to manage complex disease states.
APS is dedicated to preventing Respiratory Syncytial Virus (RSV) in qualified babies since 2001.
Our diligent tracking and monitoring of patients receiving Synagis® is unsurpassed.
APS was the receiver of the Cal Optima 2014 Circle of Care Award.
Please visit this page to find the appropriate PDF form you need.
APS is sensitive to the needs of parents of premature infants provide RSV resource links to help answer parent’s concerns.
The APS Outlook
Advanced Pharmacy and Respiratory Care Solutions vision is to support revolutionary health care management and treatment in the post critical, homecare setting by providing the most appropriate and cost effective means of improving patient’s lives.
What APS Strives For
We are dedicated to providing our clients the benefits of our local streamlined operations with the most cost competitive prices and customized data reporting base to demonstrate the effectiveness of our program to you, our partner and client. Our mission is providing the most cost-effective homecare modalities.
Established in 1985, We’ve Been Open For 38 Years
Largest and #1 Synagis® Provider In California
The Average Length of APS Employment is 11 Years
Dosing Adherence To Our At-Risk Premature Infant Synagis® Patients
We are passionate about achieving excellence
We are passionate about achieving excellence in enhancing the quality of our patient’s lives while consistently improving our clinical pharmacy practice and our at-home respiratory life-support services.
To learn more, please contact us by clicking below.
Please contact us for help.
All of our forms can be found by clicking the button below, they are PDFs.